KIFC1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
<1E-12 |
Normal-vs-Stage2 |
7.41500000289719E-08 |
Normal-vs-Stage3 |
9.5470997774072E-10 |
Normal-vs-Stage4 |
5.57770496456556E-11 |
Stage1-vs-Stage2 |
5.962800E-01 |
Stage1-vs-Stage3 |
3.786400E-02 |
Stage1-vs-Stage4 |
7.54130000000242E-05 |
Stage2-vs-Stage3 |
1.840850E-01 |
Stage2-vs-Stage4 |
8.423400E-04 |
Stage3-vs-Stage4 |
2.162200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62447832963153E-12 |
Normal-vs-AfricanAmerican |
3.76709999971858E-07 |
Normal-vs-Asian |
8.515600E-02 |
Caucasian-vs-AfricanAmerican |
3.591900E-02 |
Caucasian-vs-Asian |
3.524400E-01 |
AfricanAmerican-vs-Asian |
3.472000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
<1E-12 |
Normal-vs-Female |
1.62458935193399E-12 |
Male-vs-Female |
1.964630E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.154850E-04 |
Normal-vs-Age(41-60Yrs) |
1.62492241884138E-12 |
Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
Normal-vs-Age(81-100Yrs) |
2.00879999999737E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.734800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.115000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.783900E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.775400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.606320E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.074230E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.23760000003692E-06 |
Normal-vs-Grade 2 |
1.11022302462516E-16 |
Normal-vs-Grade 3 |
1.62581059726108E-12 |
Normal-vs-Grade 4 |
2.77860001673957E-09 |
Grade 1-vs-Grade 2 |
3.116000E-01 |
Grade 1-vs-Grade 3 |
1.359720E-02 |
Grade 1-vs-Grade 4 |
1.593300E-04 |
Grade 2-vs-Grade 3 |
2.766400E-02 |
Grade 2-vs-Grade 4 |
3.564500E-04 |
Grade 3-vs-Grade 4 |
8.422700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.62436730732907E-12 |
Normal-vs-ccB subtype |
9.15933995315754E-13 |
ccA subtype-vs-ccB subtype |
1.600310E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.62481139653892E-12 |
Normal-vs-N1 |
1.438800E-04 |
N0-vs-N1 |
1.079520E-03 |
|
|